SCHEMBL7653539

SCHEMBL7653539

N=C(N)c1ccc(NC(=O)c2ccccc2-c2ccccc2C(=O)NO)cc1

nearest known ligand 0.68

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PLAU P00749 11/20 0.68
F2 P00734 11/20 0.68
PLAT P00750 10/20 0.68
F10 P00742 10/20 0.68
PLG P00747 6/20 0.68
KLK1 P06870 4/20 0.61
KLK5 Q9Y337 4/20 0.61
PRSS1 P07477 2/20 0.57
PRSS2 P07478 2/20 0.57
PRSS3 P35030 2/20 0.57
F7 P08709 1/20 0.57
F3 P13726 1/20 0.57
TMPRSS6 Q8IU80 1/20 0.53
ST14 Q9Y5Y6 1/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2C9 P11712 1/20 0.53
ALOX12 P18054 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7661279 0.90 PLAU (0.62) PLAUF2PLATF10PLG
SCHEMBL7652151 0.90 F10 (0.65) PLAUF2PLATF10PLG
SCHEMBL7661930 0.89 CYP3A4 (0.69) PLAUF2PLATF10PLG
Hydrochloric Acid SCHEMBL7655131 0.87 CYP3A4 (0.68) PLAUF2PLATF10PLG
SCHEMBL7663670 0.86 F10 (0.60) PLAUF2PLATF10PLG
SCHEMBL7662144 0.86 F2 (0.65) PLAUF2PLATF10PLG
SCHEMBL7660234 0.84 PLAU (0.66) PLAUF2PLATF10PLG
Hydrochloric Acid SCHEMBL7654805 0.84 PLAU (0.61) PLAUF2PLATF10PLG
SCHEMBL7657788 0.83 NPC1 (0.53) PLAUF2PLATF10PLG
SCHEMBL7677631 0.83 PLAU (0.65) PLAUF2PLATF10PLG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6358960-B1 FOR THERAPY OF INTRAVASCULAR COAGULATION, CORONARY THROMBOSIS, CEREBRAL INFARCTION, CEREBRAL EMBOLISM, TRANSIENT ISCHEMIC ATTACK, CEREBROVASCULAR DISORDERS, PULMONARY VASCULAR DISEASES, DEEP VENOUS THROMBOSIS, ETC. ONO PHARMACEUTICAL CO., LTD. (JP) 2002-03-19 US claimed
EP-1078917-A1 AMIDINO DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2001-02-28 EP claimed
US-6358960-B1 FOR THERAPY OF INTRAVASCULAR COAGULATION, CORONARY THROMBOSIS, CEREBRAL INFARCTION, CEREBRAL EMBOLISM, TRANSIENT ISCHEMIC ATTACK, CEREBROVASCULAR DISORDERS, PULMONARY VASCULAR DISEASES, DEEP VENOUS THROMBOSIS, ETC. ONO PHARMACEUTICAL CO., LTD. (JP) 2002-03-19 US disclosed
EP-1078917-A1 AMIDINO DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2001-02-28 EP disclosed